260 related articles for article (PubMed ID: 29402455)
1. Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.
Kane AF; Bhatia AD; Denning PW; Shane AL; Patel RM
J Pediatr; 2018 Apr; 195():73-79.e2. PubMed ID: 29402455
[TBL] [Abstract][Full Text] [Related]
2. Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants.
Uberos J; Aguilera-Rodríguez E; Jerez-Calero A; Molina-Oya M; Molina-Carballo A; Narbona-López E
Br J Nutr; 2017 Apr; 117(7):994-1000. PubMed ID: 28443531
[TBL] [Abstract][Full Text] [Related]
3. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study.
Manzoni P; Lista G; Gallo E; Marangione P; Priolo C; Fontana P; Guardione R; Farina D
Early Hum Dev; 2011 Mar; 87 Suppl 1():S35-8. PubMed ID: 21295418
[TBL] [Abstract][Full Text] [Related]
4. Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with Lactobacillus GG in combination with bovine lactoferrin.
Meyer MP; Alexander T
J Neonatal Perinatal Med; 2017; 10(3):249-255. PubMed ID: 28854514
[TBL] [Abstract][Full Text] [Related]
5. Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG.
Luoto R; Matomäki J; Isolauri E; Lehtonen L
Acta Paediatr; 2010 Aug; 99(8):1135-8. PubMed ID: 20219023
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial.
Manzoni P; Meyer M; Stolfi I; Rinaldi M; Cattani S; Pugni L; Romeo MG; Messner H; Decembrino L; Laforgia N; Vagnarelli F; Memo L; Bordignon L; Maule M; Gallo E; Mostert M; Quercia M; Bollani L; Pedicino R; Renzullo L; Betta P; Ferrari F; Alexander T; Magaldi R; Farina D; Mosca F; Stronati M
Early Hum Dev; 2014 Mar; 90 Suppl 1():S60-5. PubMed ID: 24709463
[TBL] [Abstract][Full Text] [Related]
7. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
Pammi M; Suresh G
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007137. PubMed ID: 28658720
[TBL] [Abstract][Full Text] [Related]
8. Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect.
; ; . PubMed ID: 29198543
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
